| |
| |
| |
| Skeletal Development | |
| |
| |
| |
| PTHrP and Skeletal Development | |
| |
| |
| |
| |
| Regulating Bone Growth with BMPs | |
| |
| |
| |
| |
| BMP and BMP Inhibitors in Bone | |
| |
| |
| |
| |
| BMP Signaling and Skeletalogensis | |
| |
| |
| |
| |
| Function of BMP and BMP Antagonist in Adult Bone | |
| |
| |
| |
| |
| Dysregulation of the BMP4 Signaling Pathway in Fibrodysplasia Ossificans Progressiva | |
| |
| |
| |
| |
| Hypoxia, HIF-1???? and VHL in Chondrogenesis | |
| |
| |
| |
| |
| Cellular and Molecular Mechanisms of Synovial Joint and Articular Cartilage Formation | |
| |
| |
| |
| |
| Multiple Roles of Hoxc8 in Skeletal Development | |
| |
| |
| |
| |
| Skeletal Remodeling | |
| |
| |
| |
| Osteoclasts and Integrins | |
| |
| |
| |
| |
| Regulation of Osteoclast Differentiation | |
| |
| |
| |
| |
| Signaling in Osteoclast and their Precursors | |
| |
| |
| |
| |
| Canonical Wnt Signaling in Osteoblasts is Required for Osteoclast Differentiation | |
| |
| |
| |
| |
| Inhibition of ATF4 Transcriptional Activity by TIAT/????-Taxilin Modulates Bone Mass | |
| |
| |
| |
| |
| Paget's Disease of Bone and Genetic Disorders of RANK/OPG/RANK/NF-????B signaling | |
| |
| |
| |
| |
| The Regulation of Cathepsin K Gene Expression | |
| |
| |
| |
| |
| Direct and Indirect Estrogen Actions on Osteoblasts and Osteoclasts | |
| |
| |
| |
| |
| Molecular Mechanism of the Life and Death of the Osteoclast | |
| |
| |
| |
| |
| Understanding Parathyroid Hormone Action | |
| |
| |
| |
| |
| New Insights Into the Mechanisms Involved in The Pleiotropic Actions of 1,25dihydroxyvitamin D3 | |
| |
| |
| |
| |
| Mechanisms of Vitamin D Receptor Action | |
| |
| |
| |
| |
| Role of Connexin 43 in Osteoblast Response to Physical Load | |
| |
| |
| |
| |
| Interactive Effect of Interleukin-6 and Prostaglandin E2 on Osteoclastogenesis via the OPG/RANK-L/RANK System | |
| |
| |
| |
| |
| Does TNF Have Anti-Osteoclastogenic Actions? | |
| |
| |
| |
| |
| Eosinophil Chemotactic Factor-L (ECF-L) Enhances Osteoclast Formation by Increasing ICAM-1 Expression | |
| |
| |
| |
| |
| Mechanisms Of Bone Loss | |
| |
| |
| |
| Bone Cell Precursors and the Pathophysiology of Bone Loss | |
| |
| |
| |
| |
| Autosomal Dominant Pseudohypoparathyroidism Type 1b is Caused by Different Microdeletions Within or Upstream of the GNAS Locus | |
| |
| |
| |
| |
| Estrogen Regulation of Immune Cells Bone Interactions | |
| |
| |
| |
| |
| Autoimmunity and Bone | |
| |
| |
| |
| |
| Non-Steroid Immune Modulators and Bone Disease | |
| |
| |
| |
| |
| Pathogenesis of Osteopenia/Osteoporosis Induced by Highly Active Anti-Retroviral Therapy for AIDS | |
| |
| |
| |
| |
| Pituitary Hormones and Bone Loss | |
| |
| |
| |
| |
| Bone Destruction in Multiple Myeloma | |
| |
| |
| |
| |
| Osteogenic Regulation of Vascular Calcification | |
| |
| |
| |
| |
| The OPG/TRAIL Complex in an In Vitro Osteoclastogenesis Model Dervied From Human Multiple Myeloma Bone Disease | |
| |
| |
| |
| |
| Restoration of Bone Mass in hpg Mouse by Preoptic Area Grafting | |
| |
| |
| |
| |
| IL-7 Drives T Cell-Medicated Bone Loss Following Ovariectomy | |
| |
| |
| |
| |
| Restoring Skeletal Strength | |
| |
| |
| |
| Stem Cells and Tissue Engineering: Past, Present and Future | |
| |
| |
| |
| |
| Bisphosphonates: From Bench to Bedside | |
| |
| |
| |
| |
| Novel Targets and Therapeutics for Bone Loss | |
| |
| |
| |
| |
| Advanced Imaging Assessment of Bone Quality | |
| |
| |
| |
| |
| Bone Strength: Current Concepts | |
| |
| |
| |
| |
| Anti-Catabolic Therapeutic Target in Bone Disease | |
| |
| |
| |
| |
| Mechanisms Involved in Skeleton Anabolic Therapies | |
| |
| |
| |
| |
| Misconceptions About Calcimimetics | |
| |
| |
| |
| |
| Osteoblastic Activation in the Hematopoetic Stem Cell Niche | |
| |
| |
| |
| |
| Circulating Cells with O | |